Stage 2 T1D
Showing 1 - 25 of >10,000
Type 1 Diabetes, Prediabetic State, Dysglycemia Trial in Aurora (Early CGM-guided education and initiation of insulin therapy.,
Enrolling by invitation
- Type 1 Diabetes
- +3 more
- Early CGM-guided education and initiation of insulin therapy.
- Usual care: glucometer surveillance and basic education.
-
Aurora, ColoradoBarbara Davis Center
May 6, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +13 more
- Anastrozole
- +9 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Advanced Solid Tumors Trial in Belgium, Germany, Spain (Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR)
Recruiting
- Advanced Solid Tumors
- Autologous CD8+ T-cells, transduced with MAGE-A1 directed TCR
-
Ghent, Belgium
- +2 more
Jun 23, 2022
Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,
Not yet recruiting
- Recurrent Bladder Carcinoma
- +2 more
- Pharmacokinetic Study
- Recombinant EphB4-HSA Fusion Protein
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))
Recruiting
- Diabetes Mellitus, Type 1
- Antithymocyte Globulin
- Placebo (for ATG)
-
Gainesville, FloridaUniversity of Florida
Jan 5, 2023
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +27 more
- Fluorouracil
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)
Recruiting
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Intensity-Modulated Radiation Therapy
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Nov 8, 2022
Colorectal Adenocarcinoma, Colorectal Carcinoma Metastatic in the Lung, Stage IV Colorectal Cancer AJCC v8 Trial in Canada,
Recruiting
- Colorectal Adenocarcinoma
- +5 more
- Chemotherapy
- Metastasectomy
-
Boston, Massachusetts
- +7 more
Apr 19, 2022
Colorectal Cancer Trial
Completed
- Colorectal Cancer
- (no location specified)
Nov 8, 2023
HER2-positive Breast Cancer Trial in Ireland (trastuzumab deruxtecan (T-DXd) (IV))
Not yet recruiting
- HER2-positive Breast Cancer
- trastuzumab deruxtecan (T-DXd) (IV)
-
Galway, Connaught, Ireland
- +4 more
Jan 24, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Type 1 Diabetes Trial in Salt Lake City (FAMS-T1D, Digital resources for diabetes)
Recruiting
- Type 1 Diabetes
- FAMS-T1D
- Digital resources for diabetes
-
Salt Lake City, UtahUniversity of Utah
Apr 7, 2023
Type 1 Diabetes (T1D) Trial in Gainesville (L. johnsonii Probiotic, Placebo Capsule)
Recruiting
- Type 1 Diabetes (T1D)
- L. johnsonii Probiotic
- Placebo Capsule
-
Gainesville, FloridaUF Clinical Research Center
Sep 26, 2022
Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)
Recruiting
- Melanoma Stage III
- Melanoma Stage IV
-
Amsterdam, NH, NetherlandsAntoni van Leeuwenhoek ziekenhuis
Feb 11, 2022
Type 1 Diabetes Trial (teplizumab)
Not yet recruiting
- Type 1 Diabetes
- teplizumab
- (no location specified)
Mar 6, 2023